Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Consortin (CNST) is an integral membrane protein that acts as a cargo receptor in the trans-Golgi network, responsible for targeting connexins (the building blocks of gap junctions) to the plasma membrane and facilitating their recycling from the cell surface. It binds connexins and interacts with adaptor machinery to enable proper trafficking of these transmembrane proteins. Consortin is implicated in disorders involving connexin dysfunction, such as certain types of thyroid dyshormonogenesis and familial hypertrophic cardiomyopathy[1][3][5][7][9]. There is no evidence that CNST itself acts as a therapeutic target, receptor, enzyme, transporter, or transcription factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Consortin (CNST).